Drug Profile
Research programme: liquid polymer radiopharmaceuticals - Northwest Biotherapeutics/Battelle
Alternative Names: Prostate cancer radioisotope research programme - Northwest Biotherapeutics/BattelleLatest Information Update: 07 Aug 2003
Price :
$50
*
At a glance
- Originator Battelle Memorial Institute; Northwest Biotherapeutics
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Prostate cancer
Most Recent Events
- 07 Aug 2003 Discontinued - Preclinical for Prostate cancer in USA (unspecified route)
- 28 Sep 1999 Preclinical development for Prostate cancer in USA (Unknown route)